Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Compound 15e

PI3 kinase inhibitor
ALX-270-455-M001 1 mg 73.00 USD
ALX-270-455-M005 5 mg 293.00 USD
Do you need bulk/larger quantities?
Potent and specific inhibitor of phosphoinositide 3-kinasep110α isoform (IC50=0.0020µM). p110β isoform (IC50=0.016µM)p110γ isoform (IC50=0.66µM)C2β isoform (IC50=0.22µM). Inhibits proliferation of A375 melanoma cells (IC50=0.58µM). Inhibits proliferation of U87MG human glioblastoma cells (IC50=1.10.µM).Inhibits proliferation of A2780 human ovarian cells (IC50=0.27µM).

Product Details

Alternative Name:3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-phenol
Purity:≥99% (HPLC)
Appearance:White to off-white solid.
Solubility:Soluble in DMSO or dioxane.
Shipping:Ambient Temperature
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin -4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer: A.J. Folkes; J. Med. Chem. 51, 5522 (2008), Abstract;
Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors: M. Hayakawa, et al.; Bioorg. Med. Chem. 14, 6847 (2006), Abstract;

Related Literature

Download as PDF

All new literature pieces